These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23887450)

  • 1. [Mildronate in the treatment of transitory ischemic attacks].
    Maksimova MIu; Fedorova TN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):41-4. PubMed ID: 23887450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of the mildronate treatment of patients with ischemic stroke].
    Vinichuk SM
    Vrach Delo; 1991 Jul; (7):77-9. PubMed ID: 1771844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mildronate in geriatric patients with cardiac failure].
    Kalvinsh I; Visokinskas A; Bagdonas G; Knasene Iu; Lesaukaite V; Matsiyauskene Iu
    Ter Arkh; 2006; 78(9):75-7. PubMed ID: 17076229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy].
    Statsenko ME; Poletaeva LV; Turkina SV; Apukhtin AF; Dudchenko GP
    Ter Arkh; 2008; 80(10):27-30. PubMed ID: 19105409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical mechanisms of mildronate action during ischemic stress].
    Dambrova M; Daĭia D; Liepin'sh E; Kir'ianova O; Kalvin'sh I
    Lik Sprava; 2004 Mar; (2):68-74. PubMed ID: 15208880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of mildronate on life quality of patients with chronic heart failure].
    Nedoshivin AO; Petrova NN; Kutuzova AE; Perepech NB
    Ter Arkh; 1999; 71(8):10-2. PubMed ID: 10515026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mildronate in combined treatment of chronic cardiac insufficiency].
    Nedoshivin AO; Kutuzova AE; Perepech NB
    Klin Med (Mosk); 1999; 77(3):41-3. PubMed ID: 10234947
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate].
    Luchikhin LA; Pankova TB; Kakymov MI
    Vestn Otorinolaringol; 1991; (2):36-40. PubMed ID: 2048251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of mildronate in combined therapy of postinfarction chronic heart failure in patients with type 2 diabetes mellitus].
    Statsenko ME; Belenkova SV; Sporova OE; Shilina NN
    Klin Med (Mosk); 2007; 85(7):39-42. PubMed ID: 17882808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of a new Soviet-made antioxidant on the processes of lipid peroxidation in the treatment of patients with transient cerebro- vascular diseases and circulatory encephalopathy].
    Lebedeva NV; Khrapova EV; Fedorova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(7):79-82. PubMed ID: 1661491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of mildronate on hemoglobin ligand spectrum in patients with ischemic heart disease complicated by coronary insufficiency].
    Sakharchuk II; Starodub NF; Sisetskiĭ AP; Artiukh VP; Denisenko GT
    Kardiologiia; 1990 Sep; 30(9):87-8. PubMed ID: 2273751
    [No Abstract]   [Full Text] [Related]  

  • 12. Mildronate: an antiischemic drug for neurological indications.
    Sjakste N; Gutcaits A; Kalvinsh I
    CNS Drug Rev; 2005; 11(2):151-68. PubMed ID: 16007237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of mildronat with stenocardia patients].
    Dudko VA; Koshel'skaia OA; Sokolov AA
    Vrach Delo; 1989 Oct; (10):64-7. PubMed ID: 2694612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meldonium (Mildronate): Primum nоn nocere.
    Jargin SV
    Pharmacol Res; 2016 Dec; 114():294. PubMed ID: 27725310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy and safety of mildronate in emergency medical care].
    Nevzorov NM; Markevich YN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9 Pt 2):33-42. PubMed ID: 24107893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice.
    Du GH; Qiu Y; Zhang JT
    J Asian Nat Prod Res; 2000; 2(2):145-52. PubMed ID: 11252679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change of concentration endothelin-1 in rats on a background of alcohol and /or mildronate treatment].
    Sakvarelidze EP; Zakaraia MV; Megreladze TI
    Georgian Med News; 2006 Jun; (135):131-4. PubMed ID: 16905832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antioxidant activity of mildronate and L-carnitine in the treatment of patients with cerebrovascular diseases].
    Suslina ZA; Fedorova TN; Maksimova MIu; Kim EK
    Eksp Klin Farmakol; 2003; 66(3):32-5. PubMed ID: 12924230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the new metabolic preparations rikavit and mildronat on the parameters of the blood acid-base balance in humans with hypoxia].
    Serebrovs'ka ZA; Denisenko HT; Serebrovs'ka TV
    Fiziol Zh (1978); 1992; 38(1):26-31. PubMed ID: 1555722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.
    Klusa V; Pupure J; Isajevs S; Rumaks J; Gordjushina V; Kratovska A; Taivans I; Svirskis S; Viksna L; Kalvinsh I
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):323-8. PubMed ID: 17040219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.